Influence of cell differentiation on arachidonic acid metabolism in stimulated and unstimulated HL-60 cells by Taylor, Karyn L.
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
1989 
Influence of cell differentiation on arachidonic acid metabolism in 
stimulated and unstimulated HL-60 cells 
Karyn L. Taylor 
The University of Montana 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
Let us know how access to this document benefits you. 
Recommended Citation 
Taylor, Karyn L., "Influence of cell differentiation on arachidonic acid metabolism in stimulated and 
unstimulated HL-60 cells" (1989). Graduate Student Theses, Dissertations, & Professional Papers. 7476. 
https://scholarworks.umt.edu/etd/7476 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
COPYRIGHT ACT OF 1976
Th i s  is a n u n p u b l i s h e d  m a n u s c r i p t  in w h i c h c o p y r i g h t  
SUBSISTS. An y f u r t h e r  r e p r i n t i n g  of its c o n t e n t s  m u s t  b e
APPROVED BY THE AUTHOR.
Ma n s f i e l d  L i b r a r y 
Un i v e r s i t y  o f Mo n t a n a
Date : 1 9 8 9 —
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
INFLUENCE OF CELL DIFFERENTIATION ON ARACHIDONIC ACID 
METABOLISM IN STIMULATED AND UNSTIMULATED HL-60 CELLS
By
Karyn L. Taylor
8. S., Rocky Mountain College, 1984
Presented in partial fulfillment of the requirements
for the degree of 
Master of Science 
University of Montana 
1989
Approved by:
Çjfairmafp^Board of Examiners
DeTn, Graduate SrfTob
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMl Number: EP38277
All rights reserved
INFO RM ATIO N TO  ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
UMT
Publishktg
UMl EP38277
Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author.
Microform Edition ©  ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code
ProQ̂ st
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
\ 't
Taylor, Karyn L., M.S., July 1989 Microbiology
Influence of Cell Differentiation on Arachidonic acid Metabolism in Stimulated and Unstimulated HL-60 Cells (76 pp).
Director: George L. Card
Human promyelocytic HL-60 cells were differentiated and examined for the influence of arachidonic acid (AA) distribution and patterns of metabolism on products produced in response to stimulation. HL-60 cells were differentiated to macrophage/monocyte type cells with phorbol ester (PMA) or to granulocyte type cells with retinoic acid (RA). Stimulation was achieved with calcium ionophore A23187. Lipids were extracted using a Bligh and Dyer method modification, separated on two dimensional SCSI silicic acid paper or on LK6D silica gel TLCs and visualized by autoradiography.The relative phospholipid composition of all three cell types was similar: PC accounted for 63%-69% of total added label; PE 9%-16%; PI2%-7%; and PS 4%-5%. Marked differences occured in AA distribution within the three cell types. In PMA differentiated cells the neutral lipid contained 40% of the total, 18% in RA differentiated cells and <3% in undifferentiated cells. PE contained the largest portion of AA in the RA treated and undifferentiated cells, 49% and 43% respectively.The PMA treated cells contained 26% AA in their PE fraction.After differentiation, the RA treated and undifferentiated cells showed a similar pattern of AA uptake with maximum uptake at 6 hours.The PMA treated cells continued AA uptake for 8 hours. During this time the granulocyte-type cells and undifferentiated cells exhibited a turnover between the PE and PC pools while the macrophage/monocyte cells showed a turnover between the neutral lipid and PC pools.During differentiation, [^H]AA prelabeled cells lost radiolabel from the PC pool but gained in the PE and PI pools of RA treated and undifferentiated cells. PMA treated cells showed no change throughout the differentiation period.Stimulation of the three cell types generated no net change in the total phospholipid composition of any of the cell types. Stimulation resulted in reorganization of AA in all three cell types.The differences in AA distribution among the HL-60 cell types and the similarities between the undifferentiated and RA treated cells may help explain the AA metabolite production patterns seen in the three cell types.
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Chapter 1 
INTRODUCTION
Arachidonic acid (5-cis, 8~cis, ll-cis, 14-cis 
eicosatetraenoic acid) is one of the three most common C20 
polyunsaturated fatty acids in animals. It is the precursor 
of the important oxygenated eicosanoid family which includes 
the leukotrienes (LT) and lipoxins (Lx), lipoxygenase 
products, and the prostaglandins, cyclooxygenase products 
(Fig. 1).
Nonesterified arachidonic acid can be converted to a 
variety of biologically active end products. The first step 
is the release of arachidonic acid from membrane 
phospholipids, usually in response to stimulation of 
sensitive cells with such things as immune complexes, 
calcium ionophores, inflammatory stimuli and chemotactic 
peptides (49, 51). Release of arachidonic acid is the rate 
limiting step for all subsequent metabolism. Oxygen can 
then be inserted stereospecifically into unconjugated double 
bond systems (50) at positions 5, 12, and/or 15 of 
eicosanoic acids by the respective lipoxygenases. The 
products are hydroperoxy-eicosatetraenoic acids (HPETES).
The 5-lipoxygenase produces 5-HPETE which is dehydrated 
yielding an epoxy (oxido) fatty acid (e.g. LTA^) . LTA4 is 
very unstable and can be hydrolyzed to LTB^ or conjugated 
with glutathione to form LTC^ by GSH-S-transferase, LTC^ can 
then be converted to LTD* by gamma-glutamyl transpeptidase
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1. Oxygenation reactions involving arachidonic acid.
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Which may be converted to LTE* by dipeptidase (Fig. 2; 49,
51) . Recent studies have shown LTE* can be further 
metabolized to N-acetyl LTE^, LTE^ sulfoxide, -hydroxy LTÊ ,, 
6-trans LTB^, LTF^ and LTG« (55) . Leukotriene LTC*, LTD* 
and LTE* are biologically active. They are produced by and 
act primarily in host defense mechanisms, which include 
cells such as polymorphonuclear lymphocytes, mononuclear 
phagocytes and mast cells. They are also found in the 
central nervous system, and are being extensively studied in 
relation to allergy and inflammation. LTB* is a calcium 
ionophore and neutrophil chemotactant (49). Eosinophils 
generate LTC* and LTD* (19) . Leukotrienes C*, D*, and E* are 
all sulfidopeptide metabolites. Together they comprise SRS- 
A, slow reactive substance A. The biological activities of 
these leukotrienes include: increased vascular permeability
in the skin, stimulation of mucus secretion, constriction of 
the microvasculature and coronary arteries of both skin and 
lungs and effects on smooth muscle and other contractile 
cells. Leukotrienes released from the lung tissue of 
asthmatics after exposure to specific allergens appear to 
play a major pathophysiological role in immediate 
hypersensitivity reactions (49, 51).
The synthesis of leukotrienes requires 5-lipoxygenase 
activation. This enzyme catalyzes production of 5-HPETE 
from arachidonic acid by the dioxygenation of C-5 and then 
converts 5-HPETE to LTA*. Results from human leukocyte
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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5-lipoxygenases studies (49) suggest the enzyme is regulated 
by a complex, multicomponent system and requires activation 
by cofactors including Câ '*’, phospholipid and ATP (19) .
These multiple cellular stimulatory components are unique 
among mammalian 5-lipoxygenases and much remains unknown 
about the enzyme’s regulation and various stimulatory 
components.
The lipoxins are newly discovered oxygenated 
derivatives of arachidonic acid which are generated though a 
proposed epoxide intermediate. There are indications that 
both the 5- and 15-lipoxygenase pathways interact to form 
lipoxins in human leukocytes (50). The conversion of 
exogenous LTA^ to lipoxins, including LxA, in human 
platelets has also been reported (21). Lam's group has 
reported that phospholipase Az isoenzyme generated LxB from 
endogenous arachidonic acid sources in porcine leukocytes 
(34). Two conjugated tetraene lipoxins, LxA (5,6,15L- 
trihyroxy-7,9,11,13-icosatetraenoic acid) and LxB 
(5D,14,15L-trihydroxy-6,8,10,12-icosatetraenoic acid) are 
biologically active but some of their isomers are not. The 
reported activities include dose-dependent suppression of 
natural killer cells without effects to target cell binding 
or cAMP levels, chemotaxis, and lung tissue contractions, 
all of which are distinct from those of prostaglandins, 
thromboxanes, or leukotrienes (46, 49). When submicromolar 
concentrations of LxA was added to neutrophils it stimulated
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
generation of superoxide anion and degranulation without 
substantial aggregation. Lipoxin A is as potent as LTB^ 
with respect to generation of superoxide anion but two times 
less potent than either LTB* or the chemotactic peptide N- 
formyl-methionyl-leucyl-phenylalanine (fMLP) at eliciting 
degranulation (50).
Prostaglandins (PG), cyclooxygenase products, are 
produced in many cell types in response to stimuli (19).
They act as local hormones that are quickly cleared from the 
system. The biosynthesis is a three step process: 1)
cellular stimuli releases the Cgq precursor fatty acid, 
usually arachidonic acid, 2) the fatty acid is oxygenated to 
prostaglandin endoperoxide derivative PGH, 3) PGH is 
converted, depending on cell type, to the biologically 
active prostanoid forms (PGEg, PGFg, PGDg, PGIg or 
thromboxane Ag) (51). The physiological effects of PGs 
include inflammation, clotting, osmotic gradients and smooth 
muscle contraction and involve nearly every system in the 
body.
All three general classes of arachidonic acid 
metabolites are involved in normal immune responses and 
pathological responses such as immediate hypersensitivity 
and inflammation (49). Arachidonic acid itself can 
stimulate the mobilization of stored intracellular Ca^^ and 
thus increase free Ca^^ in the cytosol. In 
polymorphonuclear lymphocytes (PMNs) this results in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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activation of a Ca^^/phospholipid dependent protein kinase 
C, induction of PMN aggregation and Og radical production 
(52). Exogenous arachidonic acid partially inhibits 
ionophore stimulated LTB* production (22), The resulting 
balance between these responses may be any combination of l) 
the nature of the cellular stimulation(s), 2) the 
distribution/availability of arachidonic acid in the cell's 
phospholipid pools, and 3) the enzymes available for 
subsequent metabolism of free arachidonic acid.
There are two broad classes of stimuli for release of 
arachidonic acid - physiological, or specific, and 
pathological, or nonspecific (51). When cultured cells, 
platelets or organs are radiolabeled with polyunsaturated 
fatty acids, physiological stimulation releases arachidonic 
acid but no other sn-2 fatty acids, whereas, pathological 
stimulation releases linoleate, oleate, arachidonate and 
other fatty acids at the sn-2 position in proportion to the 
amount present. Physiological stimuli for arachidonic acid 
include hormones such as angiotensin II, bradykinin and 
epinephrine; proteases such as thrombin; and some antibody- 
antigen complexes. Responsive cells have specific receptors 
for these stimuli. Pathological stimuli, however, can 
affect any cell and include mechanical damage, ischemia, 
venoms such as mellitin, Ca^^ ionophores such as A2 3187 and 
tumor promoters such as phorbol esters.
There is essentially no free pool of arachidonic acid
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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within a resting/nonstimulated cell (29, 58). Arachidonic 
acid is almost exclusively esterified at the sn-2 position 
in a variety of phospholipids in the membrane. Arachidonate 
is not incorporated during de novo synthesis of 
glycerophospholipids, such as acylation of glycerol-3- 
phosphate or lysophosphatidic acid to give phosphatidic 
acid. Instead it is acylated at a later stage to a 
glycerolysophospholipid such as lysophosphocholine (29). 
Arachidonic acid is found in the lipids of the plasma 
membrane, endoplasmic reticulum, and possibly in the 
mitochondrion membrane (35). The majority of arachidonic 
acid is in phosphatidyl components (diacyl) which are the 
most metabolically active pool. The remaining small 
fraction is ether linked (alkylacyl or alkenylacyl) and is 
an inert or storage pool (18). Wilson et al. (58) showed 
that human platelets preferentially incorporate arachidonic 
acid and 8,11,14 eicosatrienoic acid over other free fatty 
acids. This is because platelets have two long chain acyl- 
CoA synthetases; one is active with a wide range of 
different fatty acids and the other, arachidonoyl-CoA 
synthetase, is specific for the polyunsaturated Ĉ o fatty 
acids. This specific enzyme has an optimum pH of 8 , 
requires ATP, Mg^^, CoA and arachidonic acid. It may 
control the level of free arachidonic acid, limit its 
metabolites in unstimulated cells and capture free 
extracellular arachidonic acid. When labeled, exogenous
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
arachidonic acid was added to platelets, free levels were 
kept low as the label was esterified into phospholipids 
without generation of oxygenated metabolites or much beta- 
oxidation of the added fatty acid (58). Non-arachidonic 
acid metabolite precursors (palmitic, stearic, oleic, and 
linoleic acids) had a relatively low rate of estérification 
into the phospholipids and were present in a significant 
amount in the free fatty acid pool.
When the fatty acid content of pancreatic islet 
phospholipids was determined (56) , the relative abundance of 
phospholipids was phosphatidylcholine (PC) > 
phosphatidylethanolamine (PE) > phosphatidylinositol (PI) > 
phosphatidylserine (PS). Arachidonate constituted 17% of 
the total islet fatty acid content and PC contained 43% of 
the total arachidonate in the islets. When the islets were 
incubated with [^H] arachidonic acid plus D-glucose the PC 
pool had the highest specific activity. When the islets 
were incubated with either 28mM glucose or 3mM glucose for 
30 min, the total fatty acid content of PC in the cells 
treated with the higher glucose concentration was much lower 
than those treated with 3mM glucose. This suggests PC may 
be the major source of free arachidonic acid upon 
stimulation of the islets with D-glucose, which induces 
phospholipid hydrolysis.
A study using human umbilical vein endothelial cells 
demonstrated selective incorporation of specific fatty acids
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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into various phospholipids via deacylation-reacylation 
pathways (53). Arachidonic acid, eicosatrienoic acid and 
eicosapentaneoic acid showed a high rate of incorporation 
into the total phospholipid pool but other fatty acids such 
as docosahexaenoates and monohydroxyeicosatetraenoates 
showed a low rate of incorporation. The relative amount of 
eicosanoid precursor fatty acid incorporation was PC > PE > 
PI > PS but the specific activity of [^H]arachidonic acid in 
PI was twice that of any of the other fatty acids i.e. 
arachidonic acid was preferentially incorporated into PI.
The general scheme for arachidonic acid release in the 
cell begins when receptors are activated which stimulate 
Ca^^ mobilization. Calcium activates phospholipase C which 
leads to hydrolysis of phosphoinositides. One product of 
this hydrolysis is 1 ,2-diacylglycerol which in turn 
activates protein kinase C as well as releases a small 
amount of arachidonic acid. Protein kinase C (PKC) then 
activates phospholipase A2 which specifically cleaves 
arachidonic acid from the sn-2 position in the phospholipid 
pool(s) of the cell (Fig. 3; 4, 51). The level of 
arachidonic acid in the tissue will be determined by the 
relative role of hydrolysis and reesterification by acyl- 
transferases. The reesterification could be the rate 
limiting step in different tissues (29).
The concentration of intracellular calcium is a major 
(possibly the major) controlling factor for arachidonate
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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release, though there is no clear evidence of this in vivo 
(29). Evidence does exist showing that within 10 seconds of 
Ca^^ stimulation (by way of ionophore A23187) in rabbit PMNs 
and platelets, phospholipase C preferentially broke down 
polyphosphoinositides to inositol bisphosphate and inositol 
triphosphate (39). Similar results were obtained when the 
chemotatic peptide fMLP was used to stimulate rabbit PMNs. 
Purdon et (45) reported phospholipase C activated
platelets preferentially hydrolyzed arachidonic acid 
containing species of 1,2-diacylPI. Inositol triphosphate 
(InsPg) is thought to be an intracellular messenger 
responsible for additional Ca^^ mobilization. InsPg 
biological activity correlates directly with specific and 
saturable cell membrane binding sites. Recently another 
potentially physiologically important inositol phosphate has 
been discovered - InsP^ - with a proposed function of 
regulating the amount of Ca^^ to which InsPg has access. 
Membranes of HL-60 cells (see Cell Line) have InsP^ binding 
site with a 200 tiroes higher affinity than for InsP^, though 
a definite intracellular receptor has yet to be established 
(8) .
Phospholipase C generates 1,2-diacylglycerol 
(diglyceride) in addition to the inositolpolyphosphates 
(51). These 1,2-diacylglycerides activate protein kinase C 
(PKC) in vivo and in vitro (47). Actually PKC is activated 
by the simultaneous presence of phospholipid, a diglyceride
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and Ca^^. The diglyceride-PKC interaction is highly
specific whereas the phospholipid-PKC interaction is not as 
specific. The diglyceride increases the PKC affinity for 
Ca^^ but is short lived itself because of metabolism by 
phosphorylation and lipase-mediated hydrolysis. In 
unstimulated cells PKC was found in the cytoplasm. Upon 
stimulation the kinase was translocated to the membrane 
because of its binding with the diglyceride and was 
activated by interactions with phospholipid and Ca^^. At 
the membrane it phosphorylated its substrate(s) on serine or 
threonine residues.
One of the substrates for PKC is the phospholipase Ag 
(P-1ipase Ag) inhibitory protein complex. Phosphorylation 
results in activation of P-lipase Ag (51). Stimulation of 
arachidonic acid liberation in most tissues is probably 
controlled by changes in phospholipase activity (29). In 
1983, Ballou et aj.. (3) stated arachidonic acid released 
from membrane phospholipids after Ca^^ dependent platelet 
activation served as the sole substrate for endoperoxides 
and thromboxanes which regulate various platelet functions. 
There are two proposed pathways for rapid arachidonic acid 
release from stimulated platelets: 1) the activation of P-
1ipase Ag which hydrolyses arachidonic acid from sn-2 
position of PC, PE, and to a lesser degree PS to generate 
free arachidonic acid and lysophospholipids; (PI seemed to 
be a poor substrate for P-lipase Ag) and 2) P-lipase C
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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breaks down PI to 1,2-diacylglycerol which is further broken 
down by a specific lipase to release free arachidonic acid. 
Together these two pathways account for all free arachidonic 
acid. There are arguments that PC specific P-lipase Ag 
leads to the majority of the free fatty acid (pathway 1) and 
note the diacylglycerol from PI by P-lipase C is rapidly 
converted to phosphatidic acid and not available for the 
diacylglycerol lipase pathway by P-lipase Ag. PC cleaved 
arachidonic acid rapidly leads to biologically active 
products.
Phospholipase A% selectivity in its release of 
arachidonic acid from thrombin-stimulated platelets has been 
shown (45). The primary membrane phospholipids cleaved were 
1-acyl PC and to a lesser extent 1-acyl PE, while ether 
phospholipids became enriched with arachidonic acid. After 
thrombin stimulation of human platelets all 1,2-diacyl PC 
species arachidonic acid content decreased by approximately 
50% and 1,2-diacyl PE by 20%. No changes were observed in 
non-arachidonic acid containing species. It was concluded 
that P-lipase Ag was selective for membrane phospholipids 
with arachidonic acid and it may be that these phospholipids 
are compartmentalized within the platelet membrane proximal 
to the enzyme action site. Most enzymes involved in 
phospholipid biosynthesis and metabolism are in the 
endoplasmic reticulum with cytoplasmic access, but there 
have been reports of P-lipase Ag hydrolysis/deacylation both
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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intracellularly and from the plasma and intracellular 
membranes.
Human neutrophils contain a Ca^^ dependent, cytosolic 
phospholipase with relative specificity for arachidonoyl PC 
that is optimally active at pH 8 , Calcium ionophore 
stimulation leads to enhanced phospholipase activity on l-o- 
alkyl-2-arachidonoylglycerophosphocholine (-GPC) and to a 
lesser extent 1-acyl-2-arachidonoyl-GPC (2). Bone marrow 
macrophage also exhibit an alkaline P-lipase Ag with 
selectivity for arachidonic acid (as compared to oleic or 
linoleic acids) from the sn-2 position of 1-acyl- and 1- 
alkyl-PC species upon stimulation.
Inflammatory stimuli induce P-lipase A^ in a mouse 
macrophage line to release arachidonic acid (36), A P- 
1 ipase Az that hydrolyzes l-o-hexadecyl-2-[^H] arachidonoyl- 
GPC was identified in a cytosolic fraction. It showed Ca^^ 
dependence and optimum activity at pH 8 . Preferred 
substrates were l-acyl-2-arachidonoyl-GPC > l-alky-2- 
arachidonoyl-GPC = l-acyl-2-arachidonoyl-GPE »  l-acyl-2- 
arachidonoyl-GPI. This enzyme also had specificity for sn-2 
arachidonic acid as compared to PC with linoleic or oleic 
acid at the same position.
Recent observations agreed that arachidonic acid is 
released through P-lipase A^ and P-lipase C/diacylglycerol 
lipase pathways but went on to imply involvement of G 
protein(s) in arachidonic acid release. Fluoride, which
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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directly activates G proteins, was used on permeabilized 
neutrophils (and similarly on platelets and mast cells).
The fluoride induction released arachidonic acid from the 
PI, PC and PE pools and seemed to be mediated through the 
two above mentioned pathways (42).
Different cells produce different end products from 
released arachidonic acid though they all may have the same, 
complete set of enzymes (28). Some cells produce both 
cyclooxygenase (PG) and lipoxygenase (LT) products from the 
released arachidonic acid. These metabolites of arachidonic 
acid can interact to modulate macrophage functions: PGEg
reverses LTC* stimulation of macrophage lysosomal enzyme 
released and LTC^ stimulates macrophage PGEg release (22). 
This indicated that leukotriene activation of macrophage may 
be self-regulating as PGEg inhibits cell activation. PGEg 
has been reported to inhibit rat neutrophil LTB<, synthesis. 
Therefore it is possible PGEg prevents macrophage activation 
by inhibiting leukotriene production. The coordination of 
the synthesis of the products is unclear (49). Depending on 
the type of stimuli used, whether it is a membrane stimulant 
or can by phagocytosed, different metabolites are produced 
(28). M.L. Brown suggested in 1987 that specific pools of 
arachidonic acid may provide precursors for individual 
classes of eicosanoids (13).
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CELL LINE: HL-60 cells were chosen as the tissue
culture line to be used in this project. HL-60s are 
promyelocytic cells that were established in 1977 from the 
peripheral blood leukocytes of an acute promyelocytic 
leukemia (17, 23). They are homogenous and exist in an 
arrested yet pliant state of maturation, that of an immature 
myelomonocytic line. They have receptors for fMLP and 
insulin. The doubling time is from 20-24 hours and 
approximately 10% of a population will spontaneously 
differentiate into more mature myeloid forms (26).
Phenotypic differentiation can be chemically induced. This 
change begins with an early event of G 1/0 growth arrest (or 
precommitment) followed by a late event that controls the 
particular linage differentiation. Induction also depends 
on an initial S phase-specific event (61).
A number of compounds stimulate the uncommitted HL-60 
precursors to differentiate into monocyte/macrophage cells 
or mature granulocytes (27, 63). The monocyte/macrophage 
inducers include phorbol meristate acetate (PMA, which is 
also referred to as TPA, 12-0-tetradecanoyl-phorbol-13- 
acetate), 1,25-dihydroxyvitamin D^, interferon gamma, tumor 
necrosis factor, sodium butyrate and actinomycin D. The 
granulocyte inducers include retinoic acid (RA), 
dimethylsulfoxide (DMSO), dimethyl formamide (DMF) and 
hypoxanthine. All these compounds act by arresting cell 
proliferation at the GO/1 phase followed by differentiation
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to the particular functional cell type (27, 60). In this 
study PMA and RA were used to differentiate the HL-60 cells.
Upon treatment of HL-60 cells with PMA there is a rapid 
cessation of DNA synthesis and cell proliferation. The 
cells become adherent and phagocytic, and lose azurophilic 
granules. There is an increase in levels of nicotinamide- 
adenine dinucleotidase, nonspecific esterase and acid 
phosphatase. The cells become cytocidal and cytostatic for 
tumor targets and produce surface antigens that react with 
anti-monocyte serum (54, 57). There is an increase in 
synthesis of specific genes like c-fos. c-fms and c-src and 
a decrease in others like c-myc and c-myb. Phosphorylation 
of certain nuclear proteins is also observed (32). Still 
other affects of PMA on HL-60 cells are increased polyamine 
levels, altered PC and triglyceride metabolism, decreased 
production of high molecular weight glycopeptides and 
generation of potent procoagulant activity. All of these 
are via specific receptors (57).
The PMA receptor copurifies with protein kinase C (PKC) 
suggesting the kinase may play a role in the differentiation 
process. However a study has shown that the effect of PMA 
is other than or in addition to simply activating PKC (33). 
As previously mentioned, PKC is a cytosolic enzyme until 
activated at which time it moves to the membrane. When PMNs 
were treated with PMA, there was a decrease in the number of 
[^H] cytosolic PMA binding sites by a factor of three but an
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increase of binding sites in the membrane by a factor of 
four (43). PMA stimulates a Ca^^ efflux in human platelets 
(44) and perhaps this is due to PKC actions on the plasma 
membrane Ca^^ pumps. Ebeling et a l . (20) tested synthetic
diacylglycerols (known activators of PKC) for inhibitory 
ability against PMA. C^-C^o saturated sn-1 ,2-diacylglycerols 
were found to be potent activators of partially purified 
HL-60 PKC and competitive inhibitors of phorbol dibutyrate 
to phorbol diester receptors. When HL-60 cells were treated 
with either PMA or sn-1,2-dioctanoylglycerol identical 
phosphoprotein changes and morphological characteristics of 
macrophages were seen. This added to the evidence that PMA 
mimics the effects of diacylglyceride on PKC (38). Because 
nuclear membranes share many biochemical properties with 
plasma membranes such as phospholipid content and turnover, 
maybe PMA treatment associates the PKC to the nucleus. HL- 
60 nuclei have been shown to bind phorbol ester in vitro and 
this binding was Ca^^ dependent. Compounds that activate 
PKC may increase nuclear binding of phorbol ester in situ 
(32) .
Undifferentiated HL-60 cells have a low metabolic rate 
of arachidonic acid and low P-lipase A^ activity. Unlike 
normal cells they incorporate a major portion of arachidonic 
and linoleic acids into ether lipids (storage fractions). 
However upon exposure to PMA fatty acid incorporation 
becomes similar to that of normal cells - it is incorporated
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mainly into the active phospholipid fraction (18).
PMA is highly lipophilic and readily binds to plasma 
membranes which could alter méthylation pathways and thus 
block cellular responses to certain stimuli. Membrane 
alterations associated with increased méthylation of 
phospholipids include changes in fluidity, in the number of 
agonist binding sites, in activation of adenylate cyclase 
and in Ca^^ flux. Cassileth et al. (15) looked for 
alterations in PC synthesis by transmethylation and 
exogenous choline pathways in PMA treated HL-60 cells.
Early changes (within the first 90 min of the 24-48 hr 
labeling period) showed that PC synthesized by méthylation 
of PE with a 5-adenosyl-L-methionine intermediate was 
inhibited in a dose dependent fashion as compared to PC 
synthesis from endogenous choline which was enhanced and 
correlated inversely with the inhibition of the méthylation 
pathway. Cabot et al. (14) found that PMA causes 
alterations in the amount of cellular triacylglycerols and 
ether-containing alkyldiacylglycerols and changes in 
phospholipid metabolism possibly implicating a role for 
lipids in the differentiation process. Alkyldiacylglycerol 
changes may be due to a general stimulus on neutral lipid 
synthesis or a consequence of PMA effects on
alkyldihydroxyacetone phosphate synthase, acyl-CoA reductase 
and fatty alcohol: NAD oxidoreductase all ether lipid 
metabolizing enzymes. The alterations in the phospholipids
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consisted of a marked increase of incorporation into PC 
and PE, but the mechanism was unknown.
The mechanism of RA induction of differentiation of HL- 
60 cells is largely unknown, but it may be through plasma 
membrane signal(s) (62). One report showed that RA
increased the activity of plasma membrane enzymes Na^-K^- 
ATPase and adenylate cyclase (1). RA triggered an early 
increase in intracellular concentration of Na^ and and 
increased the intracellular pH because of activation of a 
Na^/H^ exchange system. The Na* transport system stimulation 
led to the increase of intracellular Na^ concentration and 
activation of Na^-K^-ATPase which then increased the 
intracellular K* concentration.
HL-60 cells lack CRABP, a cellular binding protein 
that carries RA to the cell nucleus in some systems (9).
This plus the fact that the carboxyl group on the terminal 
carbon of RA is critical for its biological activity in 
differentiation of HL-60s suggests the RA may act after it 
is activated with CoA-SH to become retinoy1-CoA. Another 
aspect of RA that may have a role in differentiation is its 
ability to reduce the expression of the c-myc oncogene 
present in HL-60 cells (9). This gene is not rearranged but 
highly amplified - expression is 10 times that in some other 
cell lines. RA reduces this expression by 80-90% during 
induction and differentiation.
RA changes the pattern of phosphoproteins in HL-60
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cells. Abita et suggested this is probably because of a
decrease in intracellular cAMP concentrations (1). Evidence 
for overall changes in cAMP binding proteins in studies with 
HL-60 cells, both undifferentiated and differentiated, is 
inconclusive (positive and negative changes) (11). Recently 
a study on the action of cAMP binding type XI regulatory 
subunit, RII, of cAMP-dependent protein kinase on a DNA 
substrate has led to the suggestion that the RII may be the 
phosphoprotein substrate required for cAMP-directed 
transcriptional regulation. There is evidence for nuclear 
proteins involved in the regulation of differentiation- 
associated specific gene transcription. Briggs and his 
group studied RA differentiated and undifferentiated HL-60 
cells. They found the quantity of the cAMP binding protein 
did not change upon differentiation but there was a second 
form of the subunit with an altered charge present after RA 
treatment. They concluded that the regulatory subunit of 
type II cAMP-dependent protein kinase may be involved in the 
nuclear functions associated with differentiation.
HL-60 cells and two HL-60 subclones (one resistant to 
RA and one resistant to DMSO) were tested for arachidonic 
acid uptake after differentiation. After treatment of all 
three cell types with both chemicals significant increases 
of arachidonic acid uptake were observed though the 
biological significance of this is unknown (24). Studies 
using ^^C-arachidonic acid and Ca^* ionophore A23187,
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compared the lipoxygenase products of undifferentiated HL-60 
cells, DMSO and PMA differentiated cells. The study 
reported the precursor HL-60 cells were unable to produce 
LTB4, but could generate limited LTC* and LTD^. The DMSO 
induced granulocytes preferentially produced LTC* and LTD* 
where the PMA induced monocyte/macrophage cells 
preferentially generated LTB* (63) .
THESIS PROPOSAL: The human promyelocytic leukemia cell
line, HL-60, which can be differentiated with PMA to 
monocyte/macrophage cells or with retinoic acid to 
granulocytes were used as a model for studying any changes 
in the distribution or mobilization of arachidonic acid in 
the phospholipid pools as compared to each other and to 
undifferentiated cells. This cell line was chosen because 
upon differentiation the two different cell types 
preferentially produce different arachidonic acid 
metabolites. The questions to be addressed in this study 
are 1) Are there any differences in arachidonic acid 
distribution in the lipid pools of the different cell 
types? 2) Are there any differences in lipid composition in 
the different cell types? and 3) Are there any differences 
in the arachidonic acid turnover patterns in the various 
lipid pools in response to cell stimulation?
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Chapter 2 
MATERIALS AND METHODS
Tissue Culture;
1. Cells and Medium. HL-60 cells were purchased from 
American Type Culture Collection (ATCC). The cells were 
grown in Xscove's modified Dulbecco's media with L-glutamine 
and 25mM hepes buffer plus 10% heat inactivated fetal bovine 
serum (FBS). One liter of culture media contained 5 mis of 
an antibiotic mixture of penicillin (10,000 unit/ml) and 
streptomycin (10 mg/ml). The cells were maintained in a 5% 
CO2 humidified atmosphere at 37®C. Cell counts and 
viability were determined with a hemocytometer and trypan 
blue exclusion, viability was always at least 85%.
2. Storage. To maintain a frozen stock supply, HL-60 
cells were collected, centrifuged and the media/supernatant 
discarded. The cell pellet was resuspended in 2 ml of 
Xscove's media plus 20% FBS, cooled on ice for at least 15 
minutes then mixed with an equal volume of chilled Xscove's 
media plus 10% DMSO. One ml aliquots were stored overnight 
at -70°C then transferred to liquid Ng for permanent 
storage. To revive frozen cells, a 1 ml vial was thawed in 
a 37®C water bath for approximately 2 minutes and 
resuspended in 20-30 ml culture media to dilute the DMSO.
24
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Experimental Procedures:
1. Differentiation.
Macrophage/monocyte-Iike cells; HL-60 cells were 
differentiated to macrophage/monocyte-1ike cells with 
phorbol-12-myristate-13-acetate (PMA) (Sigma, St. Louis, 
Mo.). The PMA was resuspended in dimethylsulfoxide (DMSO). 
To induce differentiation, lOOng/ml of PMA was added to 
2x10® cells/ml and incubated two hours (48, 61). PMA 
treated cells presented many pseudopods and became very 
adherent to the tissue culture flask.
Granulocvte-like cells: HL-60 cells were
differentiated to granulocyte-like cells with retinoic acid 
(RA) (Sigma, St. Louis, Mo.) resuspended in ethanol to ImM. 
To differentiate the cells, luM RA was added to 2x10® 
cells/ml which were then incubated for 48 hours (1, 10, 60). 
A functional characteristic of normal peripheral blood 
granulocytes is the ability to reduce nitroblue tétrazolium 
(NET). A sample of the RA treated cells was mixed with an 
equal volume of 0.2% NET (Sigma) in Dulbecco's phospho- 
buffered saline with PMA and incubated at 37®C for 25 min.
A Wright-Giemsa stain was made to determine the number of 
cells with intracellular blue-black formazon deposits (17).
2 . Labeling. Labeling experiments used either ^^P0« 
from ICN Radiochemicals or [^H] arachidonic acid (AA) from 
NEN Research. Cells were labeled by the addition of 0.3 to
0.5 uCi[^H]AA/sample. Phospholipid was labeled by adding 50
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uCi of to the entire cell population. Steady-state
experiment labeling times were 16 hrs. Pulse-chase 
(turnover) experiments were as indicated in the results 
section.
3. Stimulation. Ionophore A23187 (Sigma) was 
resuspended in DMSO then diluted to O.lmM in ethanol. 
Stimulation of the three cell types was accomplished using a 
concentration of luM ionophore.
Lipid Extraction and Analysis:
1. Extraction. Lipid was extracted by a modification 
of the Bligh and Dyer lipid method (5). One ml cell 
suspension samples were taken at appropriate times, and put 
on ice and frozen (-20®C) to stop further metabolism.
Samples were then thawed and 0.2 ml were removed for future 
protein analysis if necessary. The remaining 0.8 ml were 
extracted by the modified Bligh and Dyer (5) method. To the 
0.8 ml cell suspensions were added 3 ml chloroform : 
methanol : .OIN HCl to give a 1:2:0.8 ratio of C:M:H20. The 
mixture was heated for 5 min at 68®C and allowed to cool to 
room temperature. The samples were centrifuged and the 
pellet resuspended in C:M:HC1 to repeat the extraction 
procedure. The supernatant was mixed with 1 ml chloroform 
and 1 ml 0.3% NaCl, centrifuged and the lower (chloroform) 
layer containing the lipids was collected. The water and 
methanol phase was reextracted with 1.5 ml chloroform. All
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chloroform extracts were pooled, evaporated to dryness and 
stored under Ng.
2. Analysis. Lipids were separated on SG81 silicic 
acid impregnated paper (59) or Silica gel LK6D thin layer 
chromatography (TLC) plates (31). The lipid extracts were 
resuspended in chloroform : methanol (2:1), 50ul of each 
sample evaporated and counted in a scintillation counter, 
and the remaining sample spotted on either paper or TLC 
plates. The solvent systems for the 2 dimension paper 
chromatography were 1®*": chloroform : methanol : diisobutyl 
ketone : acetic acid : water (23:10:45:25:4 v/v/v/v/v), and 
2"**: chloroform : methanol : di isobutyl ketone : pyridine : 
0.5M ammonium chloride buffer (30:17.5:25:35:6 v/v/v/v/v). 
The phospholipids were separated on the TLC plates using a 
chloroform : ethanol : water : triethylamine (30:34:8:35) 
solvent system, the neutral lipids migrated with the solvent 
front. After separation the chromatographs were 
autoradiographed. If the experiment had been done using 
[^H)AA as a label, previously labeled ^^P-phospholipid was 
added to the spotted samples as markers, if the experiment 
label had been no additions were needed. After 
developing the film the separated lipids were identified 
against standards and cut or scraped into scintillation 
vials and counted on a Beckman LS 7500 scintillation 
counter.
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Protein Assays;
Protein determinations were made using the Lowry 
method. A standard curve was obtained with bovine serum 
albumin (lug/ul).
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RESULTS
Cell Differentiation
Undifferentiated HL-60 cells were stained with Wright- 
Giemsa stain and appeared as uniformly purple-colored cells. 
Retinoic acid (RA) treated cells had an obviously smaller 
and/or segmented, dark nucleus and lighter cytoplasmic 
areas. The following chart indicates the percentage of 
differentiation in each cell type:
undiff. diff. % differentiation
untreated HL-60s 203 8 3.8
RA treated HL-60s 11 189 94.5
Retinoic acid treated cells (granulocytes) and 
undifferentiated HL-60 cells were added to 0.2% NET in the 
presence or absence of 200 ng of PMA. Upon sitting 
overnight the entire pellet of the RA treated cells with PMA 
was dark indicating uptake of the NET and incorporation as 
blue-black formazan deposits. The other three cell samples 
showed little to no darkening.
PMA treated cells were characteristically macrophage­
like with pseudopodia production and a grainier cytoplasm as 
compared to undifferentiated HL-60 cells. After the period
29
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of differentiation with PMA treatment the growth media was 
decanted off of the adherent cells which were washed once 
with Dulbecco's PBS before being scraped off for further 
experimentation. With this procedure approximately 100% of 
the cells used were assumed to be differentiated to 
macrophage.
Lipid Composition
HL-60 cells were grown in the presence of ^^PO^ for 4 8 
hours then divided into three portions: one untreated, one
portion treated with PMA and the third treated with RA. 
Lipids were extracted, separated, quantified and counted as 
described in Materials and Methods. The relative 
phospholipid composition of all the cell types had similar 
concentrations of the major lipids (Fig. 4).
Uptake of Arachidonic acid in Lipid Pools after 
Differentiation
Control cells and HL-60 cells differentiated with PMA
or RA were labeled for 16 hours with [^H]arachidonic acid.
Lipids were extracted, separated, identified and counted as
above. The steady-state arachidonic acid distribution in
the neutral lipid and phospholipid pools of the three cell
types is shown in Figure 5. There were marked differences
in the distribution of arachidonic acid among the three cell
types after the labeling period. In the PMA differentiated
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Figure 4 Comparison of Phospholipids in Differentiated and Undifferentiated HL-60 Cells. HL-60 cells were 
grown in the presence of then differentiated 
with retinoic acid (granulocytes), phorbol-12 
-myristate-13-acetate (macrophages) or left 
undifferentiated. Lipids from the three cell 
types were extracted by the Bligh and Dyer 
method, separated by chromatography in two 
dimensions on SG81 silicic acid impregnated 
paper, and visualized by autoradiography.
PC = phosphatidylcholine, PI =
phosphatidylinositol, PS = phosphatidylserine, PE 
= phosphatidylethanolamine.
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Figure 5. [^H]Arachidonic Acid Distribution in
Differentiated and Undifferentiated HL-60 Cells. 
HL-60 cells were differentiated with PMA or RA or 
left undifferentiated. The three cell types were 
labeled for 16 hrs then lipids extracted by the 
Bligh and Dyer method, separated by two 
dimensional chromatography and visualized by 
autoradiography.
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(macrophage/monocyte) cells the neutral lipid pool contained 
the largest portion of arachidonic acid (40% of the total) 
whereas phosphatidylethanolamine (PE) and
phosphatidylcholine (PC) contained 26% and 10% respectively. 
In contrast the major portion of the arachidonic acid in the 
RA treated (granulocyte) cells and undifferentiated cells 
was in the PE pool which contained 49% and 43% respectively. 
The neutral lipid accounted for 18% of the total 
[^H]arachidonic acid in the granulocyte type cells and less 
than 3% of the total label in the undifferentiated HL-60 
cells.
Uptake of Arachidonic acid in Lipid Pools of Differentiated 
Cells
Total [^H]arachidonic acid uptake by differentiated and 
undifferentiated HL-60 cells was determined over an 8 hour 
period after addition of the label. There were similarities 
between the RA treated and undifferentiated cells, both of 
which differed from the PMA treated cells. The PMA 
differentiated cells showed a linear uptake throughout the 8 
hour labeling period. The RA treated and undifferentiated 
cells showed a maximum uptake at 6 hours (Fig. 6). The 
macrophage/monocyte-1ike cells (Figure 7) showed a very 
rapid initial uptake of label in the neutral lipid fraction 
which then decreased from 60% to 20% of the total 
arachidonic acid added by the second hour and continued to
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Figure 6 Uptake of [^H]Arachidonic Acid by Differentiated 
and Undifferentiated HL-60 Cells. HL-60 cells 
were differentiated with either PMA or RA or left 
undifferentiated, then uptake was measured over 
an 8 hour interval following the addition of 
[^H]arachidonic acid. Lipids were extracted 
using the Bligh and Dyer method, separated on 
LK6D silica gel thin layer chromatographs and 
visualized by autoradiography.
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Figure 7 Uptake of [^H]Arachidonic Acid in Lipid Pool of 
PMA Differentiated (Macrophage/monocyte-type) HL- 
60 Cells. Experimental procedure as in Figure 6 .
A. Data as counts per minute. B. Data as percent 
of recoverd label.
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decrease to less than 10% over the remaining 8 hour test 
period. Coordinately there was a gradual rise in label in 
the phosphatidylserine (PS), phosphatidylinositol (PI) and 
PE pools. The arachidonic acid content of the PC pool 
initially decreased, corresponding to the rise in the 
neutral lipid, then rose to approximately 50% by the second 
hour and decreased to 41% by 8 hours. The RA treated and 
undifferentiated cells had continual loss of arachidonic 
acid from the PC pool for 8 hours and 6 hours respectively 
(Fig.s 8,9). This accompanied a continued uptake of 
arachidonic acid in the PE fraction and a more gradual 
increase in the PI fraction in both cases.
Turnover of Arachidonic acid during Differentiation
Cells were prelabeled with [^H]arachidonic acid, split 
and differentiated. Samples were taken over the time 
periods necessary for differentiation (2 hours for PMA 
treatment and 48 hours for RA treatment) to 
macrophage/monocyte and granulocyte-like cells as well as 
over 48 hours for the undifferentiated cells. The PMA 
treated samples showed no significant turnover in the lipid 
pools. The distribution of arachidonic acid in each pool 
was PE 35%, PC 30%, PI 13%, PS and neutral lipids 5% 
(Fig. 10). The RA differentiated and undifferentiated 
HL-60 cells both showed a loss of about one half (15%) of 
the arachidonic acid in the PC pools over the first 16 hours
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Figure 8 Uptake of [^H]Arachidonic Acid in Lipid Pool of 
RA Differentiated (Granulocyte-type) HL-60 Cells 
Experimental procedure as in Figure 6. A. Data 
as counts per minute. B. Data as percent of 
recovered label.
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Figure 9. Uptake of [^H]Arachidonic Acid in Lipid Pool of Undifferentiated HL-60 Cells. Experimental 
procedure as in Figure 6 , A. Data as counts per 
minute. B. Data as percent of recovered label.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
39
Jes
gw
16
PE14
PC10
^ N.I. PS
0 0 . 3 1 , 3 21
Time Clr-s3
I
S
gow
PE
3 5 *
PC
20%
15%
N.I.
PS3%
0%
0 . 3
Figure 10
Time cors]
Turnover of [^H]Arachidonic Acid During 
Differentiation of HL-60 Cells by PMA. The 
cells were prelabeled 4 hrs, washed, split and 
resuspended. lOOng/ml PMA was added to one 
third of the cells and 1 ml samples taken over 
the next 2 hrs. Lipids were extracted and 
processed as usual. A. Data as counts per 
minute. B. Data as percent of recovered label,
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Figure 11 Turnover of [^H]Arachidonic Acid During Differentiation of HL-60 Cells by RA. 
Experimental procedure as outlined in Figure 10 
except luM RA was added to one third of the 
cells. A. Data as counts per minute. B. Data 
as percent of recovered label.
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Figure 12 Turnover of [^H]Arachidonic Acid in 
Undifferentiated HL-60 Cells. Experimental 
procedure as in Figure 10 except the remaining 
one third of the cells were left 
undifferentiated. A. Data as counts per minute
B. Data as percent of recovered label.
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O f  testing (Fig.s 11, 12). The PE pool however at least 
doubled its arachidonic acid content over 16 hours and PI 
had a 10% uptake of label. (In figures 11 and 12 sampling 
was continued through 48 hours but no further variations 
were observed after 16 hours.)
Turnover of Lipids in Response to Stimulation
Figures 13-18 represent the response of the major 
phospholipid pools of the three cell types upon stimulation 
with calcium ionophore A23187 as compared to unstimulated 
cells. The stimulated PMA treated cells showed no major 
changes in the phospholipid pools (Fig.s 13, 14). As seen 
in Figure 16, stimulation of the RA treated cells led to a 
5% decrease of label in the PC pool between 15 and 30 
minutes and was reversed (reincorporated) by 60 minutes. 
These changes inversely matched the changes that occurred in 
the PE pool. A similar turnover seemed to occur to a lesser 
extent upon stimulation of the undifferentiated cells 
(Figure 18).
Turnover of Arachidonic acid in Response to Stimulation 
[^H]arachidonic acid-prelabeled differentiated and 
undifferentiated cells were stimulated with calcium 
ionophore and the major phospholipid pools were compared to 
those of unstimulated, control, cells (Fig.s 19-24). Twenty 
minutes after stimulation of the PMA treated cells a
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Figure 13 Turnover of Phospholipid Fractions in PMA 
Treated HL-60 Cells. Cells were prelabeled with 
^^PO* for 24 hrs, split and one third of the 
population differentiated with lOOng/ml PMA for 
2 hrs. The cells were washed, divided and one 
half left unstimulated. Lipids were extracted 
and processed as usual. A. Data as counts per 
minute. B. Data as percent of recovered label.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
44
60
5 0
40
3 0
20
10
6 010 3 0 4 0 5 020
PC
PE
PIsphPS
Time Cmln3
•SIu
#wMo
gaus*
60%
PC
30%
PE
■ B — e Pi
sph
PS
10%
0%
4 0 SO20 3 010 GO
Time cmlnj
Figure 14 Turnover of Phospholipid Fractions in Stimulated 
PMA Treated HL-60 Cells. Cells were prelabeled, 
differentiated, washed and divided as in Figure 
13 but the other half was stimulated with luM 
A23187. A. Data as counts per minute. B. Data 
as percent of recovered label.
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Figure 15 Turnover of Phospholipid Fractions in RA Treated 
HL-60 Cells. Experimental procedures as in 
Figure 13 except luM RA was used to 
differentiate one third of the cells over 48 
hrs. A. Data as counts per minute. B. Data as 
percent of recovered label.
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Figure 16 Turnover of Phospholipid Fractions in Stimulated 
RA Treated HL-60 Cells. Cells were prelabeled, 
differentiated, washed and divided as in Figure 
15 but the other half was stimulated with 
A23187. A. Data as counts per minute. B.
Data as percent of recovered label.
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procedures as in Figure 13 except one third of 
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Figure 18 Turnover of Phospholipid Fractions in Stimulated Undifferentiated HL-60 Cells. Cells were 
prelabeled, differentiated, washed and divided 
as in Figure 17 but the other half was 
stimulated with A23187. A. Data as counts per 
minute. B. Data as percent of recovered label.
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turnover of label occurred between the PC and PE pools. The 
PE arachidonic acid content increased and the PC pool 
decreased. The change made PE the phospholipid pool with 
the highest arachidonic acid content (Figure 20). The 
neutral lipid pool changes, best seen in figures 2 0 C,D, 
showed a large increase in label upon stimulation. The 
maximum was reached 15 minutes after addition of ionophore 
and gradually declined throughout the remaining 60 minutes 
but never returned to the unstimulated level. The RA 
treated cells had an overall loss of arachidonic acid in the 
PC pool after stimulation with a significant increase in the 
neutral lipid pool (Fig. 22). The undifferentiated cells 
displayed only minor changes in the stimulated fraction. 
Fluctuations in PE began 10 minutes after stimulation and 
continued though 60 minutes when the pool reequilibrated to 
a content of 40% arachidonic acid (Fig. 24). The large 
patterns of change seen in the neutral lipid pool are not 
relevant because the pool contains less than 3% of the total 
arachidonic acid content of undifferentiated HL-60 cells.
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Figure 19. [^H] Arachidonic Acid Turnover in PMA
Differentiated HL-60 Cells. Cells were 
prelabeled with [^H]AA and treated as in Figure 
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percent of recovered label.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
51
Ë.L>
7 0 0 0
6 0 0 0
3 0 0 0
3 0 0 0
2000
1000
10 20 3 0 4 0 3 0 GO
PE
PC
PIN.I.
PAPS
I
I
g
OM
PE
PC
1 5 *
N.I,
10%
5% PAPS
0*
3 020 4 0 5 0 6 010
T i n »  C m in 3
Figure 20. [^H]Arachidonic Acid Turnover in PMA
Differentiated HL-60 Cells upon Stimulation. 
Cells were prelabeled with [ H]AA and treated as 
in Figure 14. A. Data as counts per minute. B. 
Data as percent of recovered label.
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Figure 21. [^H]Arachidonic Acid Turnover in RA
Differentiated HL-60 Cells. Cells were 
prelabeled with [®H]AA and treated as in Figure 
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percent of recovered label.
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Figure 22. [^H]Arachidonic Acid Turnover in RA
Differentiated HL-60 Cells upon Stimulation. 
Cells were prelabeled with [ H]AA and treated as 
in Figure 16. A. Data as counts per minute. B. 
Data as percent of recovered label.
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prelabeled with [^H]AA and treated as in Figure 
17. A. Data as counts per minute. B. Data as 
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Cells were prelabeled with [^H]AA and treated as 
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Chapter 4 
DISCUSSION
Arachidonic acid is an important eicosanoid, C20 fatty 
acid, in animals. Through the arachidonic acid cascade it 
becomes oxygenated. This results in a number of 
biologically significant compounds (51). Different types of 
cells preferentially produce different metabolites of 
arachidonic acid (63). Why this occurs is unknown. There 
is a range of possible answers including: the type of
cellular stimulation; the cell's sensitivity to the 
stimulation; arachidonic acid availability and the amount 
released; from which pool(s) arachidonic acid is released; 
the nature of the phospholipases activated; and/or the 
presence, distribution and activity of the specific enzymes 
of the arachidonate cascade.
The HL-60 cell line is a very good model for studying 
some of these possibilities. These cells are maintained as 
undifferentiated promyelocytic cells but upon stimulation 
will become macrophage/monocyte-like cells or granulocyte­
like cells. By starting with a single kind of cell and 
differentiating it into one of two different types of cells, 
a number of intracellular changes can be examined. In this 
study the following aspects of the three cell types were 
determined: 1) Differences in total phospholipid pools, 2)
Differences in arachidonic acid distribution within the 
phospholipid pools, and 3) Arachidonic acid mobilization
59
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from phospholipid pools.
It was found that there were no significant differences 
in the total phospholipid pools but there were marked 
differences in arachidonic acid distribution within the 
three cell types. Stimulation of the differentiated cell 
types resulted in turnover in the phosphatidylcholine (PC) 
pools. There is much evidence that PC is a/the major 
phospholipid pool and source of arachidonic acid not only in 
HL-60 cells (6 , 7, 37, 40, 64) but other types of cells as 
well including pancreatic islets (56), endothelial cells 
(53), platelets (12, 45, 51), neutrophils (2), macrophage 
(2), monocytes (25) and erythrocytes (3 0).
Initially a comparison of total phospholipid was done 
on PMA and RA differentiated and undifferentiated HL-60 
cells. All three cells were similar in major phospholipid 
distribution? PC being the most abundant, followed by PE 
then PI and PS which were approximately equal. When 
compared to undifferentiated cells, treatment with PMA 
caused the total phospholipid content to decrease in the PC 
pool but increase slightly in the PE, PI and PS pools. RA 
treatment resulted in a slight decrease in all but the PE 
pool which remained the same. This phospholipid 
distribution agrees with Naito et (40) and their studies
on HL-60 cells. The general stability of the phospholipid 
pools helps to narrow the focus of possibilities that lead 
to differences between the cell types.
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The steady-state pattern of labeled arachidonic acid 
distribution varied greatly in differentiated and 
undifferentiated cells. Distribution in the three cell 
types was as follows: macrophage/monocyte-like cells -
neutral lipid > PE > PC > PI > PS; granulocyte-like cells - 
PE > neutral lipid > PC > PI > PS; and undifferentiated HL- 
60 cells - PE > PC > PI > PS > neutral lipid. These human 
macrophage/monocyte -type cells differ in arachidonic acid 
distribution from that reported for rabbit pulmonary 
alveolar macrophage. After overnight label with 
[^H]arachidonic acid the rabbit label was dispersed in PC 
26.7%, PE 22.8%, lyso(bis)PA 13.1% and PS + PI 9.2% (16). 
When HL-60 cells were treated with DMSO and differentiated 
into granulocyte-like cells arachidonic acid distribution 
was PE 67%, PC 24%, PI 4%, neutral lipid 2%, PS 1.7% and PA 
1.2% (7). Except for the amount of arachidonic acid 
incorporated into the neutral lipid pool, the two 
granulocyte-like cells follow the same pattern. It is 
possible the different arachidonic acid metabolites produced 
by different cells results from the marked differences of 
distribution in the three cell types.
The uptake of arachidonic acid into differentiated and 
undifferentiated cells over an 8 hour period was determined. 
An initial uptake followed by a dramatic decrease was seen 
in the neutral lipid pool of the PMA treated cells. The PC 
pool appeared to take up most of the released arachidonic
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acid as well as the PE and PI pools with relatively little 
change in the PS pool. The RA treated and undifferentiated 
cells were quite similar in that both showed a turnover 
between the PC and PE pools around 5 hours after addition of 
the label. The PI pool continued to gain label throughout 
the time course in both cell types. The RA differentiated 
and undifferentiated cells have the same general 
phospholipid pattern 8 hours after addition of 
[^H]arachidonic acid as they did after an overnight labeling 
(16 hour) period. The PMA (macrophage/monocyte cells) 
differ in their arachidonic acid content in the PE and PC 
pools which are reversed between the two time periods. This 
may indicate the macrophage/monocyte cell types have a more 
dynamic arachidonic acid supply.
When uniformly prelabeled undifferentiated HL-60 cells 
were split and differentiated, the turnover of the 
arachidonic acid label was monitored throughout the 
differentiation period and showed yet another pattern of 
arachidonic acid distribution. The PMA differentiated cells 
showed no turnover in any of the pools and after 2 hours the 
arachidonic acid content was greatest in the PE pool and in 
decreasing amounts in the PC, PI, neutral lipid and PS 
pools.
There were changes seen in the RA treated cells. An 
initial decrease occurred in the PE pool which continued for 
2 hours but then the arachidonic acid content of the pool
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rose through the 16th hour when it leveled off and did not 
change for the remainder of the 48 hours. The PC pool lost 
radioactivity from time 0 to the 16 hour time point when it 
too remained unchanged. Phosphatidylinositol gradually 
gained label for 16 hours and then became inactive. A group 
studying undifferentiated HL-60 cells treated with DMSO 
reported a rapid transmethylation of PE into PC occurring 
maximally at 60 seconds after treatment (64). This was 
followed by a decrease in the PC pool and release of 
arachidonic acid. The results correspond to those seen in 
this study. Since these changes occurred before any 
morphological evidence of differentiation, it was suggested 
these early events may represent the generation of 
intracellular chemical signals of differentiation. Another 
slightly different interpretation suggests the changes in 
the arachidonic acid containing molecular species that occur 
during differentiation may play some part in preparing the 
cell for stimuli that could result in arachidonic acid 
release (40).
There were changes in the undifferentiated cells 
similar to those of the granulocyte-type cells. These 
changes were rather unexpected. The untreated cells 
suddenly showed turnover between the phospholipid pools.
This observation suggests that the alterations which 
occurred primarily within the first 1.5 hours were, at least 
in part, instigated by the handling of the cells when they
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were split and redistributed.
To determine the effect of calcium ionophore A2 3187 
stimulation of the phospholipid pools of the three cell 
types, the cells were treated as when the total phospholipid 
composition was determined. The distribution of label
within the lipid pools was the same for the two experiments 
(compare figures 13-18 with figure 4). Stimulation of the 
PMA treated cells caused no perturbations in any of the 
pools. However an apparent turnover occurred in the 
stimulated RA treated cells and to a lesser extent also in 
the stimulated undifferentiated cells, between the PC and PE 
pools. This may be a result of deacylation/reacylation 
between the different phospholipid pools. It was reversed 
within 1 hour in the granulocyte cells but not in the 
undifferentiated cells.
In contrast to the response in the phospholipid pools, 
stimulation with A23187 led to turnover in certain pools of 
arachidonic acid in all three cell types. The arachidonic 
acid distribution in the PMA treated unstimulated cells was 
PC > PE > PI > neutral lipid > PA = PS. After stimulation 
there was a decrease of arachidonic acid in the PC and PI 
pools and an increase in the PE and neutral lipid pools. 
Unstimulated human [^H]arachidonic acid prelabeled monocytes 
have been shown to hâve a time 0 arachidonic acid content in 
the PC pool of 36.9% and in the PE pool of 15.3% (25). Upon 
challenge with opsonized zymosan, 25% of the incorporated
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label was released within 30 minutes and came from the PC 
and PI pools. Phosphatidylcholine and PI are also the pools 
from which arachidonic acid is released in stimulated rabbit 
PMNs (39). This reported data closely matches that obtained 
in this study. The percent of label at time 0 was 3 5.4% in 
the PC pool and 17.3% in the PI pool. Similar findings were 
reported for fMLP stimulated guinea pig alveolar macrophage 
which also lost arachidonic acid from the PC and PI pools 
with the PE pool remaining unchanged (37). The PE pool was 
not static but arachidonic acid was released from the diacyl 
PE fraction and taken up in the alkenyl-acyl PE fraction.
In contrast stimulated rabbit alveolar macrophage only 
release arachidonic acid from PC pools (41).
Addition of A23187 calcium ionophore to the RA treated 
cells resulted in the release of arachidonic acid from the 
PC pool and an increase in the neutral lipid pool. Others 
have reported that both the PC and PE pools were the source 
of arachidonic acid release in DMSO differentiated HL-60 
cells stimulated with A23187 (6) or with N-fNle-Lue-Phe-Nle- 
Tyr-Lys (7). But in both cases lipoxygenase product 5-HETE 
was esterified back into the phospholipid and neutral lipid 
pools within 5 minutes. In thrombin induced human platelets 
a decrease of arachidonate was also observed in the PC and 
PE pools and was accompanied by an increase in free and 
oxygenated arachidonate (12). Precursor arachidonic acid 
for 12-HETE and diHETE metabolites comes from the PC and PE
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pools in rabbit, chicken, rat and dog erythrocytes as well 
(30). This data also showed increasing label in the neutral 
lipid pool beginning at 5 minutes and continuing throughout 
the test period. Whether this was reacylation of free 
arachidonic acid or estérification of arachidonic acid 
metabolites was not determined.
The undifferentiated HL-60 cells had no net change due 
to the stimulation. The decrease and subsequent increase of 
arachidonic acid in the PE fraction from 15 minutes through 
60 minutes after stimulation may be a result of 
reesterification of either the freed arachidonic acid or 
certain metabolized products back into the pool. The 
apparent loss of arachidonic acid from the neutral lipid 
pool is irrelevant as there is less than 3% of the total 
arachidonic acid content of undifferentiated cells in that 
pool.
From this study it is evident that upon differentiation 
of the HL-60 cell line into two different types of cells, 
the distribution of arachidonic acid within the phospholipid 
pools is changed. Furthermore, stimulation of the 
undifferentiated and two differentiated cell types gives 
different arachidonic acid uptake and release patterns. 
However, the patterns of the undifferentiated and RA treated 
cells are quite similar to each other and both differ from 
the PMA treated cells. This correlates with the 
similarities and differences in the arachidonic acid
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metabolites produced by each cell type. Undifferentiated 
and granulocyte-like cells produce LTC» and LTD* and PMA 
treated cells generate LTB*. A possible explanation for 
this may be the variations in arachidonic acid distribution.
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Chapter 5 
SUMMARY
Differences in arachidonic acid uptake, distribution 
and release with stimulation were studied in an uncommitted 
promyelocytic cell line (HL-60) and the two cell types into 
which it can be differentiated - macrophage/monocyte-like 
cells and granulocyte-like cells. Analogous results were 
obtained between the undifferentiated and granulocytic cells 
which both produce the same types of arachidonic acid 
metabolites. In comparison dissimilar patterns were found 
in the macrophage/monocyte cell type which generates 
different metabolic end products from arachidonic acid.
1. There were no significant differences in 
phospholipid composition among the different cell types; PC 
accounted for 63% - 69% of the total label added, PE 9% - 
16%, PS 4% - 5% and PI 2% - 7%.
2. There were marked differences in the distribution of 
arachidonic acid among the three different cell types. In 
PMA differentiated cells the neutral lipid contained 40% of 
the total, PE 26% and PC 10%. RA treated and 
undifferentiated cells contained the largest portion of 
arachidonic acid in the PE fraction with 49% and 43% 
respectively. Arachidonic acid composed 18% of the RA 
treated cells* neutral lipid pool and less than 3% of the 
undifferentiated cells' neutral lipid pool.
3. After differentiation granulocyte-like cells (RA
68
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treated) had the most rapid initial uptake of arachidonic 
acid which peaked after 6 hours. The macrophage/monocyte - 
like cells (PMA treated) showed a slower and continued 
uptake throughout 8 hours. Uptake in the undifferentiated 
cells peaked at 6 hours.
4. Over the 8 hour [^H] arachidonic acid uptake period 
tested after cell differentiation, the RA treated and 
undifferentiated cells exhibited a turnover of label between 
the PE and PC pools. The PMA treated cells had an early 
turnover between the neutral lipid pool (decrease) and the 
PC pool (increase).
5. During differentiation of [^H]arachidonic acid
prelabeled cells the PC pool lost radiolabel and the PE and 
PI pools gained counts in the RA treated and 
undifferentiated HL-60 cells. The phospholipid and neutral 
lipid pools of the PMA treated cells were unchanged 
throughout the differentiation period.
6 . Stimulation of the three cell types with calcium 
ionophore generated no net change in the total phospholipid 
composition of any of the cell types.
7. Stimulation of the three cell types with calcium 
ionophore resulted in a different reorganization of 
arachidonic acid in the two differentitated cell types. The 
neutral lipid and PC pools differed the most between these 
cell types.
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